Category Archives: ISDS

The Trans-Pacific Partnership is back: experts respond

Source: The Conversation The latest incarnation of the Trans-Pacific Partnership (TPP) is said to have “fewer bad bits”. But as our experts point out below, there’s still a great deal wrong with, or missing from, the regional free trade agreement. The new … Continue reading

Posted in ISDS, TPP, Uncategorized | Leave a comment

Govt will lose gold mine dispute due to Article 44 use: academics

Govt will lose gold mine dispute due to Article 44 use: academics By PRATCH RUJIVANAROM The Nation (Thailand) | 1 Sep 2017 BANGKOK: — Experts and academics have warned that Thailand will lose an arbitral tribunal process regarding allegations that it … Continue reading

Posted in BITS, ISDS, Uncategorized | Tagged | Leave a comment

Company sues Ukraine in bid to corner hepatitis C drug market

By Josh Kovensky, KyivPost | June 16, 2017 A doctor checks a patient for Hepatitis C in Zaporizhiya. As much as 10 percent of the Ukrainian population could be infected with the disease. Photo by UNIAN Multinational pharmaceutical firm Gilead Sciences has … Continue reading

Posted in Data Exclusivity, ISDS, Uncategorized | 2 Comments

Government should release Philip Morris plain packaging case costs says Fair Trade group

Media Release | July 10, 2017 “We welcome the international tribunal decision that Philip Morris tobacco company should pay the costs of its failed case against Australia’s 2011 plain packaging law. But it is absurd and unacceptable that the tribunal has … Continue reading

Posted in BITS, Investment treaties, ISDS, Uncategorized | Leave a comment

Lexmark: The Supreme Court’s patent exhaustion case and parallel trade in drugs

Source: Knowledge Ecology International The Supreme Court’s decision in IMPRESSION PRODUCTS, INC. v. LEXMARK INTERNATIONAL, INC.  has clarified that the United States has world wide exhaustion of patent rights.   According to Professor Fred Abbott, who knows a lot about this issue, and … Continue reading

Posted in Cancer, Delinkage, ISDS, R&D, Uncategorized, USFDA | Leave a comment

Why RCEP is the problem, not the solution

Source: inquirer.net | May 17, 2017 On May 2-12, the 16 member-countries of the Regional Comprehensive Economic Partnership (RCEP) met in Manila for their 18th round of negotiations to craft a multilateral trade deal that would affect half of the world’s … Continue reading

Posted in Investor state dispute, IP Rights, ISDS, Regional Comprehensive Economic Partnership, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

Oppose RCEP! Fight for Pro-People Trade!

People Over Profit Statement on the 18th Round of Negotiations of the Regional Comprehensive Economic Partnership (RCEP) in Manila, Philippines 10 May 2017 Amid growing dissent and discontent globally against neoliberal free trade and investment agreements (FTAs), trade negotiators from … Continue reading

Posted in ISDS, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment